Arsenic Trioxide, Itraconazole, All-Trans Retinoic Acid and Nicotinamide:
This comprehensive study delves into the intricate landscape surrounding
Nonsurgical therapies are needed for patients with multiple basal cell carcinomas (BCCs)
2017 Dec 18;4(1):10-12
Basal cells produce new skin cells
We assessed the effect of itraconazole on the HH pathway and on tumor size in human BCC tumors
Objective To determine whether administration of intravenous arsenic trioxide
Vismodegib, an antagonist of the Hedgehog component Smoothened (SMO), has been approved by the FDA for treatment of
President Joe Biden and First Lady Jill Biden were diagnosed and treated for basal cell Introduction
Kim J, Tang JY, Gong R, et al: Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth
Which treatment is best for you depends on the type, location and size of your cancer, as well as your preferences and ability to do follow-up visits
This phase 2, open-label, placebo-controlled examines topical itraconazole as a treatment for basal cell carcinoma
Computed tomography of lung metastasis before and after treatment also shows no reduction in size
1 BCC, together with squamous cell carcinoma, is grouped into the so-called nonmelanoma skin cancers which present cells with keratinocytic morphology